Neurol. praxi. 2015;16(1):20-23

Spasticity - clinical scales

doc. MUDr. Edvard Ehler, CSc.
Neurologická klinika PKN, a.s. a FZS Univerzity Pardubice

Central motoneuron lesion is manifested by negative and positive signs, that lead to an increased muscle tone and to an increased muscle acitivity. On the development of clinical picture of spastic paresis there are participating as fibroelastic muscle components just as increased muscle activity - stretch sensitive spasticity, spastic dystonia, co-contraction, flexion and extension spasms. For desciption of spastic paresis there are used various scales, that inable substantially more detailed evaluation of clinical finding and long-term monitoring.

Keywords: spastic paresis, spastic dystonia, cocontraction, clinical scales

Published: January 26, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ehler E. Spasticity - clinical scales. Neurol. praxi. 2015;16(1):20-23.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ashworth B. Preliminary trial of carisoprodal in multiple sclerosis. Practicioner 1964; 192: 540-542.
    2. Barnes MP, Johnson GR. Upper motor neurone syndrome and spasticity. Cambridge: Cambridge University Press 2001.
    3. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207. Go to original source... Go to PubMed...
    4. Boyd RN, Graham HK. Objective measurement of clinical findings in the use of botulinum toxin A i the management of children with cerebral palsy. Eur J Neurol 1999; 6(Suppl. 4): S23-S35. Go to original source...
    5. Ehler E, Vaňásková E, Štětkářová I. Standard komplexní léčby spasticity po cévní mozkové příhodě. Cesk Slov Neurol N 2009; 72/105: 179-181.
    6. Gracies JM, Bayle N, Vinti M. Five-steps clinical assessment in spastic paresis. Eur J Phys Rehabil Med 2010; 46: 411-421. Go to PubMed...
    7. Gracies JM. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes. Muscle Nerve 2005; 31: 535-551. Go to original source... Go to PubMed...
    8. Malhotra S, Pandyan AD, Rosewilliam S, Roffe C, Hermens H. Spasticity and contractures of the wrist after stroke: time course of development and their association with functional recovery of the upper limb. Clin Rehab 2011; 25: 184-191. Go to original source... Go to PubMed...
    9. Reichel G. Therapy guide spasticity-dystonia. Bremen: UNI-MED SCIENCE, 2005.
    10. Rosales RL, Kanovsky P, Fernandez HH. What's the "catch" in upper-limb post-stroke spasticity: expanding the role of botulinum toxin applications. Parkinsonism Relat Disord 2011; 17(Suppl. 1): S3-S10. Go to original source... Go to PubMed...
    11. Skinner A, Turner-Stokes L. The use of standardized outcome measures in rehabilitation centres in UK. Clin Rehabil 2006; 20(7): 609-615. Go to original source... Go to PubMed...
    12. Štětkářová I, Ehler E, Jech R. Spasticita a její léčba. Praha: Maxdorf Jesenius 2012.
    13. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticite imprime avec la periodique. Rev neurol 1954; 81: 143-144.
    14. Ward AB. A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neur 2012; 19: 21-27. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.